tiprankstipranks
Ascendis Pharma (DE:A71)
MUNICH:A71

Ascendis Pharma (A71) Financial Statements

0 Followers

Ascendis Pharma Financial Overview

Ascendis Pharma's market cap is currently ―. The company's EPS TTM is €; its P/E ratio is ―; Ascendis Pharma is scheduled to report earnings on ―, and the estimated EPS forecast is €―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 22Sep 22Jun 22Mar 22Dec 21
Income Statement-
Total Revenue-€ 15.29M€ 6.16M€ 6.83M€ 4.90M
Gross Profit-€ 13.60M€ 5.07M€ 2.58M-
EBIT-€ -127.88M€ -71.93M€ -119.86M€ -104.84M
EBITDA-€ -123.36M€ -67.54M€ -115.44M€ -100.57M
Net Income Common Stockholders-€ -168.96M€ -81.32M€ -125.50M€ -106.06M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments€ 22.93M€ 919.81M€ 955.15M€ 978.70M€ 682.06M
Total Assets€ 1.09B€ 1.27B€ 1.33B€ 1.38B€ 1.08B
Total Debt€ 482.96M€ 553.24M€ 512.21M€ 473.66M€ 104.96M
Net Debt€ 460.02M€ -366.57M€ -442.94M€ -505.04M€ -577.10M
Total Liabilities€ 826.39M€ 821.87M€ 718.99M€ 704.43M€ 201.29M
Stockholders Equity€ 0.00€ 451.55M€ 607.84M€ 672.82M€ 883.63M
Cash Flow-
Free Cash Flow-€ -102.00M€ -128.12M€ -134.61M€ -128.11M
Operating Cash Flow-€ -98.83M€ -124.39M€ -130.79M€ -123.31M
Investing Cash Flow-€ 14.10M€ 9.89M€ 38.54M€ -111.92M
Financing Cash Flow-€ -76.00K€ -2.23M€ 397.74M€ -20.63M
Currency in EUR

Ascendis Pharma Earnings and Revenue History

Ascendis Pharma Debt to Assets

Ascendis Pharma Cash Flow

Ascendis Pharma Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis